secwatch / observer
8-K filed January 10, 2025, 6:59 PM ET ticker LAB CIK 0001162194
leadership confidence high sentiment negative materiality 0.65

Standard BioTools CCO Jeremy Davis to depart Feb 1, 2025; severance details disclosed

STANDARD BIOTOOLS INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jeremy Davis

Chief Commercial Officer
LAB · STANDARD BIOTOOLS INC.
Effective
2025-02-01
Filed
January 10, 2025, 6:59 PM ET
On January 3, 2025, Standard BioTools Inc. (the “Company”) and Jeremy Davis, the Company’s Chief Commercial Officer, mutually determined that Mr. Davis will no longer serve in such position, effective as of February 1, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeremy Davis departed as Chief Commercial Officer at STANDARD BIOTOOLS INC..

Action
will no longer serve
Role
Chief Commercial Officer
Exact text from the filing
On January 3, 2025, Standard BioTools Inc. (the “Company”) and Jeremy Davis, the Company’s Chief Commercial Officer, mutually determined that Mr. Davis will no longer serve in such position, effective as of February 1, 2025.
View on SEC.gov

STANDARD BIOTOOLS INC. filing history →

Source: SEC EDGAR
accession 0000950170-25-004155
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.